Scharnweber Tim, Santos Catarina, Franke Ralf-Peter, Almeida Maria Margarida, Costa Maria Elisabete V
Institute for Biological Interfaces; Forschungszentrum Karlsruhe GmbH, 76344 Eggenstein- Leopoldshafen Karlsruhe, Germany.
Molecules. 2008 Nov 1;13(11):2729-39. doi: 10.3390/molecules13112729.
In our previous work we described the preparation and characterization of spray dried hydroxyapatite micro granules loaded with 5-fluorouracil (5-FU). These loaded particles are used as a model drug delivery system (DDS). In this study we examined the in vitro response of two cell lines derived from different tissues to 5-FU loaded granules (LG). Both cell lines, either L929 cells of a mouse fibroblast lineage or cells originating from a rat osteosarcoma (ROS 17/2.8) showed a dose dependent decrease in cell proliferation in response to 5-FU-, either dissolved in the culture medium or loaded onto particles. The response of the two cell lines to loaded and nonloaded particles was different. The effect of LG and of a corresponding concentration of free 5-FU was practically the same for the ROS 17/2.8 cells indicating that ROS 17/2.8 cells were not affected by the carrier material. In contrast, L929 cells showed a slight decrease in cell proliferation also in the presence of granules not loaded with 5-FU. This is thought to be attributed to the inhibition of mitogenesis by phosphocitrates, already demonstrated in fibroblasts. In summary, we found that the loaded 5-FU kept its effectivity after the spray drying process and that the response towards the granules varied with cell type. This is the first step towards a tissue specific DDS.
在我们之前的工作中,我们描述了负载5-氟尿嘧啶(5-FU)的喷雾干燥羟基磷灰石微粒的制备及表征。这些负载微粒用作模型药物递送系统(DDS)。在本研究中,我们检测了源自不同组织的两种细胞系对负载5-FU的微粒(LG)的体外反应。两种细胞系,即小鼠成纤维细胞系的L929细胞或源自大鼠骨肉瘤的细胞(ROS 17/2.8),对溶解于培养基中或负载于微粒上的5-FU均表现出细胞增殖的剂量依赖性降低。两种细胞系对负载和未负载微粒的反应不同。对于ROS 17/2.8细胞,LG和相应浓度游离5-FU的作用基本相同,表明ROS 17/2.8细胞不受载体材料影响。相反,在存在未负载5-FU的微粒时,L929细胞的细胞增殖也略有下降。这被认为归因于磷酸柠檬酸盐对有丝分裂的抑制,这在成纤维细胞中已得到证实。总之,我们发现负载的5-FU在喷雾干燥过程后仍保持其有效性,并且对微粒的反应因细胞类型而异。这是迈向组织特异性DDS的第一步。